The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3R,5R,7R)-N-((1S,4S)-4-(24(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8(7H)-yl)cyclohexyl)adamantane-1-carboxamide ID: ALA4873395
PubChem CID: 164620416
Max Phase: Preclinical
Molecular Formula: C37H49N7O3
Molecular Weight: 639.84
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(C)cc(=O)n([C@H]3CC[C@@H](NC(=O)C45CC6CC(CC(C6)C4)C5)CC3)c2n1
Standard InChI: InChI=1S/C37H49N7O3/c1-23-14-33(45)44(28-6-4-27(5-7-28)39-35(46)37-19-24-15-25(20-37)17-26(16-24)21-37)34-30(23)22-38-36(41-34)40-31-9-8-29(18-32(31)47-3)43-12-10-42(2)11-13-43/h8-9,14,18,22,24-28H,4-7,10-13,15-17,19-21H2,1-3H3,(H,39,46)(H,38,40,41)/t24?,25?,26?,27-,28+,37?
Standard InChI Key: UJKWXLQWGNFZFP-MLJQLJJWSA-N
Molfile:
RDKit 2D
47 54 0 0 0 0 0 0 0 0999 V2000
11.2427 -11.9357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8504 -11.2841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0086 -11.7226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5292 -11.5384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7214 -12.0092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2392 -11.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0048 -10.9130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5332 -10.2857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8482 -10.5311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2474 -10.5827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5239 -9.4603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2329 -9.0384 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8034 -9.0576 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7906 -8.2339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0701 -7.8310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0585 -7.0023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7674 -6.5803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4880 -6.9830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4996 -7.8119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6047 -5.3689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3252 -5.7757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0341 -5.3537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0184 -4.5249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2979 -4.1222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5930 -4.5441 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7324 -4.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4530 -4.5068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4657 -5.3306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7517 -5.7514 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1863 -5.7334 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7167 -3.2752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8980 -5.7894 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1803 -5.3882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4713 -5.8101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7498 -5.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7421 -4.5836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4470 -4.1616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1686 -4.5634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0165 -4.1797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3076 -4.6017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5859 -4.2040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5743 -3.3751 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2832 -2.9532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0089 -3.3570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8537 -2.9724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4820 -6.6379 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7771 -7.0640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
2 4 1 0
3 5 1 0
4 6 1 0
5 6 1 0
7 8 1 0
3 7 1 0
2 9 1 0
6 10 1 0
10 8 1 0
8 9 1 0
11 12 2 0
11 13 1 0
8 11 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
14 19 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
20 25 2 0
26 27 2 0
27 28 1 0
28 29 1 0
22 29 1 0
23 26 1 0
28 30 2 0
26 31 1 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
33 38 2 0
39 40 1 0
40 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
39 44 1 0
42 45 1 0
36 39 1 0
46 47 1 0
34 46 1 0
32 33 1 0
20 32 1 0
17 29 1 1
14 13 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 639.84Molecular Weight (Monoisotopic): 639.3897AlogP: 5.42#Rotatable Bonds: 7Polar Surface Area: 104.62Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 14.00CX Basic pKa: 7.84CX LogP: 5.08CX LogD: 4.50Aromatic Rings: 3Heavy Atoms: 47QED Weighted: 0.35Np Likeness Score: -1.16
References 1. Huang M, Huang Y, Guo J, Yu L, Chang Y, Wang X, Luo J, Huang Y, Tu Z, Lu X, Xu Y, Zhang Z, Zhang Z, Ding K.. (2021) Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors., 211 [PMID:33248853 ] [10.1016/j.ejmech.2020.113023 ]